cloudfront

Report Detail

Pharma & HealthcareGlobal Synthetic Opioids Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM2414433
  • |
  • 14 September, 2018
  • |
  • Global
  • |
  • 119 pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Global Synthetic Opioids Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

    1 Market Overview

    • 1.1 Synthetic Opioids Introduction
    • 1.2 Market Analysis by Type
    • 1.2.1 Methadone
  • 1.2.2 Fentanyl
  • 1.2.3 Meperidine
  • 1.2.4 Hydrocodone
  • 1.2.5 Oxymorphone
  • 1.2.6 Oxycodone
  • 1.3 Market Analysis by Applications
  • 1.3.1 Pain Management
  • 1.3.2 De-addiction
  • 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
  • 1.4.1.1 United States Market States and Outlook (2013-2023)
  • 1.4.1.2 Canada Market States and Outlook (2013-2023)
  • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
  • 1.4.2.1 Germany Market States and Outlook (2013-2023)
  • 1.4.2.2 France Market States and Outlook (2013-2023)
  • 1.4.2.3 UK Market States and Outlook (2013-2023)
  • 1.4.2.4 Russia Market States and Outlook (2013-2023)
  • 1.4.2.5 Italy Market States and Outlook (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • 1.4.3.1 China Market States and Outlook (2013-2023)
  • 1.4.3.2 Japan Market States and Outlook (2013-2023)
  • 1.4.3.3 Korea Market States and Outlook (2013-2023)
  • 1.4.3.4 India Market States and Outlook (2013-2023)
  • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  • 1.4.4 South America, Middle East and Africa
  • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
  • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
  • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
  • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
  • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
  • 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force
  • 2 Manufacturers Profiles

    • 2.1 Purdue Pharma
    • 2.1.1 Business Overview
  • 2.1.2 Synthetic Opioids Type and Applications
  • 2.1.2.1 Product A
  • 2.1.2.2 Product B
  • 2.1.3 Purdue Pharma Synthetic Opioids Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.2 Pfizer
  • 2.2.1 Business Overview
  • 2.2.2 Synthetic Opioids Type and Applications
  • 2.2.2.1 Product A
  • 2.2.2.2 Product B
  • 2.2.3 Pfizer Synthetic Opioids Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.3 Janssen Pharmaceuticals
  • 2.3.1 Business Overview
  • 2.3.2 Synthetic Opioids Type and Applications
  • 2.3.2.1 Product A
  • 2.3.2.2 Product B
  • 2.3.3 Janssen Pharmaceuticals Synthetic Opioids Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.4 Teva Pharmaceuticals
  • 2.4.1 Business Overview
  • 2.4.2 Synthetic Opioids Type and Applications
  • 2.4.2.1 Product A
  • 2.4.2.2 Product B
  • 2.4.3 Teva Pharmaceuticals Synthetic Opioids Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.5 Endo International
  • 2.5.1 Business Overview
  • 2.5.2 Synthetic Opioids Type and Applications
  • 2.5.2.1 Product A
  • 2.5.2.2 Product B
  • 2.5.3 Endo International Synthetic Opioids Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.6 West-Ward Pharmaceuticals
  • 2.6.1 Business Overview
  • 2.6.2 Synthetic Opioids Type and Applications
  • 2.6.2.1 Product A
  • 2.6.2.2 Product B
  • 2.6.3 West-Ward Pharmaceuticals Synthetic Opioids Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.7 Mallinckrodt Pharmaceuticals
  • 2.7.1 Business Overview
  • 2.7.2 Synthetic Opioids Type and Applications
  • 2.7.2.1 Product A
  • 2.7.2.2 Product B
  • 2.7.3 Mallinckrodt Pharmaceuticals Synthetic Opioids Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.8 Mylan
  • 2.8.1 Business Overview
  • 2.8.2 Synthetic Opioids Type and Applications
  • 2.8.2.1 Product A
  • 2.8.2.2 Product B
  • 2.8.3 Mylan Synthetic Opioids Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.9 Impax Laboratories
  • 2.9.1 Business Overview
  • 2.9.2 Synthetic Opioids Type and Applications
  • 2.9.2.1 Product A
  • 2.9.2.2 Product B
  • 2.9.3 Impax Laboratories Synthetic Opioids Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.10 Indivior
  • 2.10.1 Business Overview
  • 2.10.2 Synthetic Opioids Type and Applications
  • 2.10.2.1 Product A
  • 2.10.2.2 Product B
  • 2.10.3 Indivior Synthetic Opioids Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 3 Global Synthetic Opioids Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Synthetic Opioids Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Synthetic Opioids Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
    • 3.3.1 Top 3 Synthetic Opioids Manufacturer Market Share in 2017
  • 3.3.2 Top 6 Synthetic Opioids Manufacturer Market Share in 2017
  • 3.4 Market Competition Trend
  • 4 Global Synthetic Opioids Market Analysis by Regions

    • 4.1 Global Synthetic Opioids Sales, Revenue and Market Share by Regions
    • 4.1.1 Global Synthetic Opioids Sales and Market Share by Regions (2013-2018)
  • 4.1.2 Global Synthetic Opioids Revenue and Market Share by Regions (2013-2018)
  • 4.2 North America Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 4.3 Europe Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 4.4 Asia-Pacific Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 4.5 South America Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 4.6 Middle East and Africa Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 5 North America Synthetic Opioids by Countries

    • 5.1 North America Synthetic Opioids Sales, Revenue and Market Share by Countries
    • 5.1.1 North America Synthetic Opioids Sales and Market Share by Countries (2013-2018)
  • 5.1.2 North America Synthetic Opioids Revenue and Market Share by Countries (2013-2018)
  • 5.2 United States Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 5.3 Canada Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 5.4 Mexico Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 6 Europe Synthetic Opioids by Countries

    • 6.1 Europe Synthetic Opioids Sales, Revenue and Market Share by Countries
    • 6.1.1 Europe Synthetic Opioids Sales and Market Share by Countries (2013-2018)
  • 6.1.2 Europe Synthetic Opioids Revenue and Market Share by Countries (2013-2018)
  • 6.2 Germany Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 6.3 UK Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 6.4 France Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 6.5 Russia Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 6.6 Italy Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 7 Asia-Pacific Synthetic Opioids by Countries

    • 7.1 Asia-Pacific Synthetic Opioids Sales, Revenue and Market Share by Countries
    • 7.1.1 Asia-Pacific Synthetic Opioids Sales and Market Share by Countries (2013-2018)
  • 7.1.2 Asia-Pacific Synthetic Opioids Revenue and Market Share by Countries (2013-2018)
  • 7.2 China Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 7.3 Japan Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 7.4 Korea Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 7.5 India Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 7.6 Southeast Asia Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 8 South America Synthetic Opioids by Countries

    • 8.1 South America Synthetic Opioids Sales, Revenue and Market Share by Countries
    • 8.1.1 South America Synthetic Opioids Sales and Market Share by Countries (2013-2018)
  • 8.1.2 South America Synthetic Opioids Revenue and Market Share by Countries (2013-2018)
  • 8.2 Brazil Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 8.3 Argentina Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 8.4 Colombia Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 9 Middle East and Africa Synthetic Opioids by Countries

    • 9.1 Middle East and Africa Synthetic Opioids Sales, Revenue and Market Share by Countries
    • 9.1.1 Middle East and Africa Synthetic Opioids Sales and Market Share by Countries (2013-2018)
  • 9.1.2 Middle East and Africa Synthetic Opioids Revenue and Market Share by Countries (2013-2018)
  • 9.2 Saudi Arabia Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 9.3 UAE Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 9.4 Egypt Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 9.5 Nigeria Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 9.6 South Africa Synthetic Opioids Sales and Growth Rate (2013-2018)
  • 10 Global Synthetic Opioids Market Segment by Type

    • 10.1 Global Synthetic Opioids Sales, Revenue and Market Share by Type (2013-2018)
    • 10.1.1 Global Synthetic Opioids Sales and Market Share by Type (2013-2018)
  • 10.1.2 Global Synthetic Opioids Revenue and Market Share by Type (2013-2018)
  • 10.2 Methadone Sales Growth and Price
  • 10.2.1 Global Methadone Sales Growth (2013-2018)
  • 10.2.2 Global Methadone Price (2013-2018)
  • 10.3 Fentanyl Sales Growth and Price
  • 10.3.1 Global Fentanyl Sales Growth (2013-2018)
  • 10.3.2 Global Fentanyl Price (2013-2018)
  • 10.4 Meperidine Sales Growth and Price
  • 10.4.1 Global Meperidine Sales Growth (2013-2018)
  • 10.4.2 Global Meperidine Price (2013-2018)
  • 10.5 Hydrocodone Sales Growth and Price
  • 10.5.1 Global Hydrocodone Sales Growth (2013-2018)
  • 10.5.2 Global Hydrocodone Price (2013-2018)
  • 10.6 Oxymorphone Sales Growth and Price
  • 10.6.1 Global Oxymorphone Sales Growth (2013-2018)
  • 10.6.2 Global Oxymorphone Price (2013-2018)
  • 10.7 Oxycodone Sales Growth and Price
  • 10.7.1 Global Oxycodone Sales Growth (2013-2018)
  • 10.7.2 Global Oxycodone Price (2013-2018)
  • 11 Global Synthetic Opioids Market Segment by Application

    • 11.1 Global Synthetic Opioids Sales Market Share by Application (2013-2018)
    • 11.2 Pain Management Sales Growth (2013-2018)
    • 11.3 De-addiction Sales Growth (2013-2018)

    12 Synthetic Opioids Market Forecast (2018-2023)

    • 12.1 Global Synthetic Opioids Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Synthetic Opioids Market Forecast by Regions (2018-2023)
    • 12.2.1 North America Synthetic Opioids Market Forecast (2018-2023)
  • 12.2.2 Europe Synthetic Opioids Market Forecast (2018-2023)
  • 12.2.3 Asia-Pacific Synthetic Opioids Market Forecast (2018-2023)
  • 12.2.4 South America Synthetic Opioids Market Forecast (2018-2023)
  • 12.2.5 Middle East and Africa Synthetic Opioids Market Forecast (2018-2023)
  • 12.3 Synthetic Opioids Market Forecast by Type (2018-2023)
  • 12.3.1 Global Synthetic Opioids Sales Forecast by Type (2018-2023)
  • 12.3.2 Global Synthetic Opioids Market Share Forecast by Type (2018-2023)
  • 12.4 Synthetic Opioids Market Forecast by Application (2018-2023)
  • 12.4.1 Global Synthetic Opioids Sales Forecast by Application (2018-2023)
  • 12.4.2 Global Synthetic Opioids Market Share Forecast by Application (2018-2023)
  • 13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
    • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
  • 13.2 Distributors, Traders and Dealers
  • 14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Opioids is extracted from opioid (poppy) alkaloid derivatives in vivo and in vitro, and interact with central specific receptor, can relieve pain, produce happiness is extracted from opioid (poppy) alkaloid derivatives in vivo and in vitro, and interact with central specific receptor, can relieve pain, create happiness.

      Scope of the Report:

      This report focuses on the Synthetic Opioids in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Rise in the number of patients suffering from terminal illnesses such as a severe cough resulting from lung infection, cancer, HIV, along with a high surge in the prescription for post-operative pain medication are factors expected to boost the consumption of semi-synthetic opioids as pain medication.

      The worldwide market for Synthetic Opioids is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

      Market Segment by Manufacturers, this report covers

      Purdue Pharma

      Pfizer

      Janssen Pharmaceuticals

      Teva Pharmaceuticals

      Endo International

      West-Ward Pharmaceuticals

      Mallinckrodt Pharmaceuticals

      Mylan

      Impax Laboratories

      Indivior

      Market Segment by Regions, regional analysis covers

      North America (United States, Canada and Mexico)

      Europe (Germany, France, UK, Russia and Italy)

      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

      South America (Brazil, Argentina, Colombia etc.)

      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers

      Methadone

      Fentanyl

      Meperidine

      Hydrocodone

      Oxymorphone

      Oxycodone

      Market Segment by Applications, can be divided into

      Pain Management

      De-addiction

      There are 15 Chapters to deeply display the global Synthetic Opioids market.

      Chapter 1, to describe Synthetic Opioids Introduction, product scope, market overview, market opportunities, market risk, market driving force;

      Chapter 2, to analyze the top manufacturers of Synthetic Opioids, with sales, revenue, and price of Synthetic Opioids, in 2016 and 2017;

      Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

      Chapter 4, to show the global market by regions, with sales, revenue and market share of Synthetic Opioids, for each region, from 2013 to 2018;

      Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

      Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

      Chapter 12, Synthetic Opioids market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

      Chapter 13, 14 and 15, to describe Synthetic Opioids sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source




      Summary:
      Get latest Market Research Reports on Synthetic Opioids . Industry analysis & Market Report on Synthetic Opioids is a syndicated market report, published as Global Synthetic Opioids Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Synthetic Opioids market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,336.82
      3,505.23
      4,673.64
      3,202.30
      4,803.44
      6,404.59
      421,567.20
      632,350.80
      843,134.40
      230,770.63
      346,155.95
      461,541.26
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report